Skip to main content

Advertisement

Log in

Toll-Like Receptor 2 Antagonist Ameliorates Type 2 Diabetes Mellitus Associated Neuropathic Pain by Repolarizing Pro-inflammatory Macrophages

  • Original Paper
  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

Diabetic neuropathy is one of the common complications of type 2 diabetes mellitus (T2DM) with severe outcomes. The mechanisms of physiopathology of diabetic neuropathy are not well elucidated. Inflammation and inflammatory macrophages are recognized to be crucial in diabetic neuropathy. Toll-like receptor 2 (TLR2) is an important factor in innate immune response which could promote the polarization of inflammatory macrophages. In present study, we evaluated the effects of a TLR2 antagonist CU-CPT22 on diabetic neuropathy. We induced T2DM in mice by feeding with high fat diet (HFD). We measured the body weight, blood glucose level, paw withdrawal threshold, inflammatory cytokine production, and macrophages infiltration in T2DM mice. We evaluated the effects of CU-CPT22 on pro-inflammatory cytokines production, macrophage marker expression in lipopolysaccharides (LPS)-treated BMDMs. We administrated CU-CPT22 in T2DM mice and measured the pro-inflammatory cytokines levels, expression of macrophages markers in sciatic nerve (SCN), and paw withdrawal threshold. T2DM mice had significantly increased body weight and blood glucose, and had significantly decreased paw withdrawal threshold. Obvious increased pro-inflammatory cytokine level and infiltration of M1 phenotype macrophages was observed in SCN from T2DM mice. CU-CPT22 prevented pro-inflammatory cytokine production in LPS-treated BMDMs and re-polarized them to M2 phenotype. CU-CPT22 suppressed the inflammation and induced M2 macrophages in SCN from T2DM mice, and ameliorated the paw withdrawal threshold in T2DM mice. CU-CPT22 ameliorates neuropathic pain in T2DM by promoting M2 phenotype macrophages.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Data Availability

Data will be made available on reasonable request.

References

  1. Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, Malik RA, Maser RE, Sosenko JM, Ziegler D, American Diabetes A (2005) Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 28:956–962

    Article  Google Scholar 

  2. Selvin E, Parrinello CM, Sacks DB, Coresh J (2014) Trends in prevalence and control of diabetes in the United States, 1988–1994 and 1999–2010. Ann Intern Med 160:517–525

    Article  Google Scholar 

  3. Donath MY, Shoelson SE (2011) Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 11:98–107

    Article  CAS  Google Scholar 

  4. Pop-Busui R, Ang L, Holmes C, Gallagher K, Feldman EL (2016) Inflammation as a therapeutic target for diabetic neuropathies. Curr Diab Rep 16:29

    Article  Google Scholar 

  5. Mirza S, Hossain M, Mathews C, Martinez P, Pino P, Gay JL, Rentfro A, McCormick JB, Fisher-Hoch SP (2012) Type 2-diabetes is associated with elevated levels of TNF-alpha, IL-6 and adiponectin and low levels of leptin in a population of Mexican Americans: a cross-sectional study. Cytokine 57:136–142

    Article  CAS  Google Scholar 

  6. Schenk S, Saberi M, Olefsky JM (2008) Insulin sensitivity: modulation by nutrients and inflammation. J Clin Invest 118:2992–3002

    Article  CAS  Google Scholar 

  7. Mora C, Navarro JF (2006) Inflammation and diabetic nephropathy. Curr Diab Rep 6:463–468

    Article  CAS  Google Scholar 

  8. Navarro JF, Mora C (2006) Diabetes, inflammation, proinflammatory cytokines, and diabetic nephropathy. Scientific World J 6:908–917

    Article  CAS  Google Scholar 

  9. Shi X, Chen Y, Nadeem L, Xu G (2013) Beneficial effect of TNF-alpha inhibition on diabetic peripheral neuropathy. J Neuroinflammation 10:69

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Davies LC, Jenkins SJ, Allen JE, Taylor PR (2013) Tissue-resident macrophages. Nat Immunol 14:986–995

    Article  CAS  Google Scholar 

  11. Biswas SK, Mantovani A (2010) Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol 11:889–896

    Article  CAS  Google Scholar 

  12. Gordon S, Martinez FO (2010) Alternative activation of macrophages: mechanism and functions. Immunity 32:593–604

    Article  CAS  Google Scholar 

  13. Kiguchi N, Kobayashi D, Saika F, Matsuzaki S, Kishioka S (2017) Pharmacological Regulation of Neuropathic Pain Driven by Inflammatory Macrophages. Int J Mol Sci. https://doi.org/10.3390/ijms18112296

    Article  PubMed  PubMed Central  Google Scholar 

  14. Kraakman MJ, Murphy AJ, Jandeleit-Dahm K, Kammoun HL (2014) Macrophage polarization in obesity and type 2 diabetes: weighing down our understanding of macrophage function? Front Immunol 5:470

    Article  Google Scholar 

  15. DiPenta JM, Green-Johnson JM, Murphy RJ (2007) Type 2 diabetes mellitus, resistance training, and innate immunity: is there a common link? Appl Physiol Nutr Metab 32:1025–1035

    Article  Google Scholar 

  16. Ahmad R, Al-Mass A, Atizado V, Al-Hubail A, Al-Ghimlas F, Al-Arouj M, Bennakhi A, Dermime S, Behbehani K (2012) Elevated expression of the toll like receptors 2 and 4 in obese individuals: its significance for obesity-induced inflammation. J Inflamm (Lond) 9:48

    Article  CAS  Google Scholar 

  17. Creely SJ, McTernan PG, Kusminski CM, Fisher FM, Da Silva NF, Khanolkar M, Evans M, Harte AL, Kumar S (2007) Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab 292:E740-747

    Article  CAS  Google Scholar 

  18. Morris J, Williams N, Rush C, Govan B, Sangla K, Norton R, Ketheesan N (2012) Burkholderia pseudomallei triggers altered inflammatory profiles in a whole-blood model of type 2 diabetes-melioidosis comorbidity. Infect Immun 80:2089–2099

    Article  CAS  Google Scholar 

  19. Caricilli AM, Nascimento PH, Pauli JR, Tsukumo DM, Velloso LA, Carvalheira JB, Saad MJ (2008) Inhibition of toll-like receptor 2 expression improves insulin sensitivity and signaling in muscle and white adipose tissue of mice fed a high-fat diet. J Endocrinol 199:399–406

    Article  CAS  Google Scholar 

  20. Elzinga S, Murdock BJ, Guo K, Hayes JM, Tabbey MA, Hur J, Feldman EL (2019) Toll-like receptors and inflammation in metabolic neuropathy; a role in early versus late disease? Exp Neurol 320:e112967

    Article  Google Scholar 

  21. Gong W, Huang F, Sun L, Yu A, Zhang X, Xu Y, Shen Y, Cao J (2018) Toll-like receptor-2 regulates macrophage polarization induced by excretory-secretory antigens from Schistosoma japonicum eggs and promotes liver pathology in murine schistosomiasis. PLoS Negl Trop Dis 12:e0007000

    Article  CAS  Google Scholar 

  22. Quero L, Hanser E, Manigold T, Tiaden AN, Kyburz D (2017) TLR2 stimulation impairs anti-inflammatory activity of M2-like macrophages, generating a chimeric M1/M2 phenotype. Arthritis Res Ther 19:245

    Article  Google Scholar 

  23. Xu L, Tang D, Guan M, Xie C, Xue Y (2014) Effect of high-fat diet on peripheral neuropathy in C57BL/6 mice. Int J Endocrinol: https://doi.org/10.1155/2014/305205

    Article  Google Scholar 

  24. O’Brien PD, Sakowski SA, Feldman EL (2014) Mouse models of diabetic neuropathy. Ilar j 54:259–272

    Article  CAS  Google Scholar 

  25. Watcho P, Stavniichuk R, Ribnicky DM, Raskin I, Obrosova IG (2010) High-fat diet-induced neuropathy of prediabetes and obesity: effect of PMI-5011, an ethanolic extract of Artemisia dracunculus L. Mediators Inflamm. https://doi.org/10.1155/2010/268547

    Article  PubMed  PubMed Central  Google Scholar 

  26. Saika F, Kiguchi N, Matsuzaki S, Kobayashi D, Kishioka S (2019) Inflammatory macrophages in the sciatic nerves facilitate neuropathic pain associated with type 2 diabetes mellitus. J Pharmacol Exp Ther 368:535–544

    Article  CAS  Google Scholar 

  27. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL (1994) Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53:55–63

    Article  CAS  Google Scholar 

  28. Weischenfeldt J, Porse B (2008) Bone marrow-derived macrophages (BMM): isolation and applications. CSH Protoc. https://doi.org/10.1101/pdb.prot5080

    Article  PubMed  Google Scholar 

  29. Mantovani A, Biswas SK, Galdiero MR, Sica A, Locati M (2013) Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol 229:176–185

    Article  CAS  Google Scholar 

  30. Martyn JA, Kaneki M, Yasuhara S (2008) Obesity-induced insulin resistance and hyperglycemia: etiologic factors and molecular mechanisms. Anesthesiology 109:137–148

    Article  Google Scholar 

  31. Guilford BL, Ryals JM, Wright DE (2011) Phenotypic changes in diabetic neuropathy induced by a high-fat diet in diabetic C57BL/6 mice. Exp Diabetes Res. https://doi.org/10.1155/2011/848307

    Article  PubMed  PubMed Central  Google Scholar 

  32. Obrosova IG, Ilnytska O, Lyzogubov VV, Pavlov IA, Mashtalir N, Nadler JL, Drel VR (2007) High-fat diet induced neuropathy of pre-diabetes and obesity: effects of “healthy” diet and aldose reductase inhibition. Diabetes 56:2598–2608

    Article  CAS  Google Scholar 

  33. Vincent AM, Hayes JM, McLean LL, Vivekanandan-Giri A, Pennathur S, Feldman EL (2009) Dyslipidemia-induced neuropathy in mice: the role of oxLDL/LOX-1. Diabetes 58:2376–2385

    Article  CAS  Google Scholar 

  34. Gordon S, Taylor PR (2005) Monocyte and macrophage heterogeneity. Nat Rev Immunol 5:953–964

    Article  CAS  Google Scholar 

  35. Murray PJ (2017) Macrophage Polarization. Annu Rev Physiol 79:541–566

    Article  CAS  Google Scholar 

  36. Wynn TA, Chawla A, Pollard JW (2013) Macrophage biology in development, homeostasis and disease. Nature 496:445–455

    Article  CAS  Google Scholar 

  37. Kiguchi N, Maeda T, Kobayashi Y, Fukazawa Y, Kishioka S (2010) Macrophage inflammatory protein-1alpha mediates the development of neuropathic pain following peripheral nerve injury through interleukin-1beta up-regulation. Pain 149:305–315

    Article  CAS  Google Scholar 

  38. Kellogg AP, Wiggin TD, Larkin DD, Hayes JM, Stevens MJ, Pop-Busui R (2007) Protective effects of cyclooxygenase-2 gene inactivation against peripheral nerve dysfunction and intraepidermal nerve fiber loss in experimental diabetes. Diabetes 56:2997–3005

    Article  CAS  Google Scholar 

  39. Feng TT, Yang XY, Hao SS, Sun FF, Huang Y, Lin QS, Pan W (2020) TLR-2-mediated metabolic reprogramming participates in polyene phosphatidylcholine-mediated inhibition of M1 macrophage polarization. Immunol Res 68:28–38

    Article  CAS  Google Scholar 

  40. Pahwa R, Jialal I (2016) Hyperglycemia Induces Toll-Like Receptor Activity Through Increased Oxidative Stress. Metab Syndr Relat Disord 14:239–241

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The study was supported by Medical Science Research Project of Hebei Province (20191458).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tieying Song.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 79 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tian, J., Song, T., Wang, H. et al. Toll-Like Receptor 2 Antagonist Ameliorates Type 2 Diabetes Mellitus Associated Neuropathic Pain by Repolarizing Pro-inflammatory Macrophages. Neurochem Res 46, 2276–2284 (2021). https://doi.org/10.1007/s11064-021-03365-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11064-021-03365-3

Keywords

Navigation